Nurse Practitioner · Huntley, IL
NPI
1891465043
Since 2021
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
10350 Haligus Rd Ste A
Huntley, IL, 60142
Phone (847) 802-7500
Groups this clinician bills Medicare through
Medicare paid, 2024
$345K
13,566 services
Medicare patients, 2024
974
Average age 76
Drug cost, 2024
$5.5M
2,773 prescriptions
Company payments, 2025
$1,633
From 15 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David Degrassi was code J0897 (injection, denosumab, 1 mg), 7,680 times for 47 patients. In total David Degrassi billed 13,566 services in 43 codes, and Medicare paid $345K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2021-12-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J0897 Injection, denosumab, 1 mg | Office | 7,680 | 47 | $20.62 | $158K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 959 | 662 | $11.49 | $11K |
| 99214 Office E&M - Established | Office | 833 | 581 | $88.42 | $74K |
| 81003 Clinical Chemistry | Office | 531 | 429 | $2.19 | $1,164 |
| 99213 Office E&M - Established | Office | 410 | 335 | $60.98 | $25K |
| J9217 Leuprolide acetate (for depot suspension), 7.5 mg | Office | 281 | 36 | $140.40 | $39K |
| 51798 Ultrasound - Nonspecific | Office | 178 | 151 | $8.98 | $1,598 |
| 36415 Venipuncture Blood Collection | Office | 144 | 110 | $8.65 | $1,246 |
| 99232 Hospital E&M - Subsequent | Facility | 94 | 67 | $56.12 | $5,275 |
| 96372 Injection Administration | Office | 79 | 48 | $10.35 | $817 |
| 96402 Chemotherapy Administration | Office | 60 | 36 | $25.66 | $1,540 |
| 99222 Hospital E&M - Initial | Facility | 50 | 48 | $94.07 | $4,704 |
| 99233 Hospital E&M - Subsequent | Facility | 34 | 26 | $85.80 | $2,917 |
| 74018 Standard X-ray | Office | 30 | 30 | $19.87 | $596 |
| 51701 Other Organ Systems | Office | 26 | 25 | $32.64 | $849 |
By year: 2022 $48K for 850 services; 2023 $78K for 2,659 services; 2024 $345K for 13,566 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 81003 Clinical Chemistry | 531 | 429 | $2.19 | $1,164 |
| 36415 Venipuncture Blood Collection | 144 | 110 | $8.65 | $1,246 |
Medicare prescription drug claims, 2024
In 2024, the drug David Degrassi prescribed most often to Medicare patients was Tamsulosin Hcl, with 624 prescriptions and refills. In total David Degrassi wrote 2,773 Medicare prescriptions that cost $5.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Tamsulosin Hcl Generic | 624 | 1,580 | 269 | $11K |
| Orgovyx Relugolix | 470 | 470 | 83 | $1.2M |
| Xtandi Enzalutamide | 323 | 323 | 57 | $3.6M |
| Finasteride Generic | 270 | 705 | 105 | $3,530 |
| Dutasteride Generic | 111 | 323 | 48 | $3,493 |
| Abiraterone Acetate Generic | 98 | 98 | 14 | $131K |
| Myrbetriq Mirabegron | 86 | 157 | 27 | $64K |
| Prednisone Generic | 76 | 80 | 18 | $285 |
| Gemtesa Vibegron | 56 | 122 | 26 | $57K |
| Alfuzosin Hcl Er Alfuzosin Hcl | 43 | 95 | 21 | $942 |
| Ampicillin Trihydrate Generic | 41 | 41 | 39 | $472 |
| Doxycycline Hyclate Generic | 37 | 37 | 35 | $284 |
| Sulfamethoxazole-Trimethoprim Sulfamethoxazole/Trimethoprim | 36 | 38 | 33 | $122 |
| Nitrofurantoin Mono-Macro Nitrofurantoin Monohyd/M-Cryst | 35 | 35 | 33 | $454 |
| Solifenacin Succinate Generic | 34 | 82 | 17 | $3,408 |
Brand drugs: - claims; generic drugs: 1,781 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David Degrassi $1,633 ($1,633 in general payments such as food, travel and fees) from 15 companies. The largest payer was Janssen Biotech, Inc. with $502.
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. JNJ | 9 | $502 |
| Astellas Pharma US Inc 4503.T | 7 | $246 |
| Dendreon Pharmaceuticals LLC | 7 | $221 |
| Ferring Pharmaceuticals Inc. | 2 | $159 |
| Urogen Pharma, Inc. URGN | 1 | $109 |
| Sumitomo Pharma America, Inc. 4506.T | 5 | $108 |
| Abbvie Inc. ABBV | 4 | $103 |
| Profound Medical Corp. PROF | 2 | $41.55 |
| Olympus America Inc. | 1 | $33.94 |
| Avyxa Pharma, LLC | 1 | $24.73 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.